OBJECTIVE-The worldwide prevalence of obesity is increasing at an alarming rate, along with the associated increased rates of type 2 diabetes, heart disease, and some cancers. While efforts to address environmental factors responsible for the recent epidemic must continue, investigation into the anorectic functions of potential molecules we present here, such as apolipoprotein (apo)E, offers exciting possibilities for future development of successful anti-obesity therapies.RESEARCH DESIGN AND METHODS-Changes in feeding behavior after intracerebroventricular injection of apoE, the regulation of hypothalamic apoE gene expression by energy status, and the interaction of hypothalamic apoE with other neuropeptides were studied.RESULTS-Intracerebroventricular apoE significantly decreased food intake without causing malaise, whereas intracerebroventricular infusion of apoE antiserum stimulated feeding, implying that endogenous apoE tonically inhibits food intake. Consistent with this, apoE was present in the hypothalamus, a brain site intimately involved in the integration of signals for energy homeostasis. Fasted rats exhibited significantly decreased apoE gene expression in the hypothalamus, and refeeding of these rats for 4 h evoked a significant increase of hypothalamic apoE mRNA levels. Both genetically obese (ob/ob) mice and rats with high-fat diet-induced obesity had significantly reduced hypothalamic apoE mRNA levels compared with their lean control counterparts, suggesting that decreased apoE may contribute to hyperphagia in these obese animals. Additionally, apoE-stimulated hypothalamic proopiomelanocortin gene expression and SHU9119, a melanocortin 3/4 receptor antagonist, attenuated the inhibitory function of apoE on feeding.CONCLUSIONS-These data demonstrate that apoE suppresses food intake via a mechanism enhancing melanocortin signaling in the hypothalamus. Diabetes 57:2092-2098, 2008 E levated body weight resulting in obesity is a major health problem in the U.S. and is associated with significant morbidity and mortality from coronary heart disease, type 2 diabetes, and other disorders. One well-established risk factor for becoming obese is food consumption in excess of energy expenditure. Evidence links a complex circuitry in the mediobasal hypothalamus with the control of food intake and energy expenditure. Obese animals have a blunted response to satiation signals such as leptin and insulin, raising the possibility that defective satiation signaling within the central nervous system and/or peripheral tissues may contribute to the etiology of obesity.Apolipoprotein (apo)E, a 34,000-kDa glycoprotein involved in lipid metabolism (1), is predominantly produced in the liver and brain (2). Recent data suggest that apoE plays additional roles in the brain, regulating both neuronal and astrocyte functions, including preventing excitotoxicity (3), promoting neuron survival and sprouting (4), protecting neurons against oxidative stress (5), and regulating innate and adaptive immune responses (6). We here descr...